• Cardamomin, Oxidative Damage, and Ischemic Stroke

  2026-09-02

  This study connects cardamomin from Amomum villosum stems and leaves with protection against hydrogen peroxide-induced oxidative damage in BV-2 cells and injury in a rat permanent middle cerebral artery occlusion model. Its main mechanistic contribution is the integration of MEK/ERK-dependent NRF2 activation with suppression of AIFM1-associated oxeiptosis and parthanatos, while TTC staining provides a tissue-level outcome measure.

• Glutamine Metabolism in HSCs and Liver Fibrosis

  2026-09-02

  Yin et al. show that glutamine catabolism sustains hepatic stellate cell activation and that the mitochondrial regulator SIRT4 can suppress this process by restraining GDH activity. The study connects SIRT4, GDH, α-ketoglutarate production, and fibrotic progression, suggesting a metabolic strategy for limiting liver fibrosis while highlighting important translational uncertainties.

• Tropisetron Hydrochloride: Receptor & Transporter Guide

  2026-09-01

  Tropisetron Hydrochloride is a selective 5-HT3 receptor antagonist used to investigate serotonin 5-HT3 receptor pathway biology and related transporter effects. Supplier-reported potency, solubility, identity, and storage specifications support controlled neuroscience receptor modulation and in vitro pharmacology workflows.

• Network Medicine Identifies Apigenin for Alzheimer’s

  2026-09-01

  A 2025 study used network proximity analysis to screen flavonoids against Alzheimer’s disease-associated targets and identified Apigenin as the strongest candidate among four experimentally tested compounds. Cellular validation linked its neuroprotective activity to preservation of mitochondrial function, reduced apoptosis, AKT/NF-κB pathway modulation, and regulation of microglial inflammatory states.

• Bortezomib (PS-341) as a Proteostasis Probe

  2026-08-31

  Bortezomib (PS-341) is more than a cytotoxic control: it can help distinguish proteasome-dependent stress from autophagic protein clearance in cancer assays. This guide translates FOXM1 pathway findings into a rigorous experimental framework for apoptosis, proteostasis, and drug-resistance research.

• Geneticin in Cell Selection and Metabolic Assays

  2026-08-31

  Geneticin is more than a selection reagent: its translation-blocking activity can influence the metabolic phenotypes measured in engineered cells. This guide connects G418 selection with glutamine-metabolism studies in hepatic stellate cells, emphasizing assay design, controls, and interpretation.

• DRB at the Transcription–Translation Interface

  2026-08-30

  5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) can help translational researchers separate transcriptional supply from RNA modification and translation effects. This thought-leadership guide connects DRB-based perturbation with recent findings on ac4C-modified lncRNA Gm26917 in female germline stem cells, while defining practical boundaries for antiviral and stem-cell research.

• Angiotensin I/II (1-5) Workflow Guide

  2026-08-29

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure and aldosterone-related endpoints. It is best suited to cardiovascular and renal workflows, and should not be substituted for full-length angiotensin peptides or used in unrelated signaling assays without validation.

• Fasting, Translatome Remodeling, and Tumorigenesis

  2026-08-28

  Yang and colleagues show that fasting suppresses global liver translation while selectively increasing translation of mRNAs required for lipid catabolism and ketogenesis through phosphorylated eIF4E. The study identifies a fatty acid–AMPK–MNK–eIF4E circuit and connects this metabolic translation program to pancreatic tumor growth during a ketogenic diet.

• Restoring PTEN with Translational mRNA Design

  2026-08-28

  A thought-leadership guide to using EZ Cap™ Human PTEN mRNA (ψUTP) for mechanistic cancer research, pathway validation, delivery studies, and translational model design.

• Anlotinib Hydrochloride: From Target to Assay

  2026-08-27

  Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor whose value in cancer research depends on interpreting receptor, pathway, and phenotype data together. This guide develops an assay-decision framework that separates VEGFR2-driven endothelial effects from broader angiogenic signaling and direct tumor-cell responses.

• SCH772984: ERK Signaling at the Resistance Edge

  2026-08-27

  A translational framework for using SCH772984, a selective ERK1/2 inhibitor, to test whether MAPK signaling connects angiotensin II, HIF-1α-HILPDA biology, ferroptosis suppression, and radioresistance in nasopharyngeal carcinoma.

• Gli1+ Progenitors in Glucocorticoid Osteoporosis

  2026-08-26

  Yang et al. identify Gli1+ metaphyseal mesenchymal progenitors as a key osteoblast-lineage population affected by glucocorticoid-induced osteoporosis. By combining inducible lineage tracing, single-cell RNA sequencing, metabolic analysis, and teriparatide treatment, the study links progenitor dysfunction to impaired bone formation and highlights a candidate cellular target for intervention.

• Spermine tetrahydrochloride: Applied Workflows

  2026-08-26

  Spermine tetrahydrochloride is a charge-based reagent for protecting bacterial protoplasts, improving protein crystallization, and crosslinking polyphosphazene nanoparticles. This guide converts published concentration ranges into practical workflows, controls, and troubleshooting decisions while separating established evidence from exploratory applications.

• CDC42–YAP–mTOR Control of Intestinal Stem Cell Fate

  2026-08-25

  Zhang et al. show that CDC42-dependent apical-basal polarity regulates the intestinal stem cell-to-transit amplifying cell transition through a YAP/TAZ–Ereg–mTOR cascade rather than canonical Wnt signaling. Conditional genetics and pharmacological rescue experiments distinguish restoration of cell-fate balance from restoration of epithelial polarity, providing a mechanistic framework for intestinal crypt homeostasis.

8072 records 1/539 page Next 12345 下5页 Last page